Development of optimal treatment tactics for XXXX withdrawal. I. Assessment and effectiveness of supportive care.

@entity1 @entity410 @entity167 @entity409 @entity1833
The relative roles of supportive care and pharmacotherapy in the treatment of @entity167 withdrawal are not established. A reliable and validated withdrawal severity assessment scale (Clinical Institute Withdrawal Assessment for @entity167 , CIWA-A) was developed to assess initially and then follow the clinical course of 38 hospitalized chronic alcoholics requiring hospitalization for withdrawal but without serious concurrent medical or surgical problems. Supportive care, consisting of standardized half-hourly @entity1 assessment (CIWA-A) and nursing care, was used as the initial treatment for all @entity1 . Twenty-eight (74%) @entity1 with clinical supportive care successes within 8 hours, 75% within 4 hours. Two responding @entity1 subsequently developed evidence of withdrawal at 48 hours ( @entity1833 ) and 72 hours ( @entity410 ). Ten @entity1 (26%) did not respond to supportive care and required drug therapy in addition. Responders to supportive care drink more by history and have less severe @entity409 than nonresponders. There are no other apparent predictors of the @entity1 who require drug therapy. Three quarters of hospitalized @entity1 , without serious medical complications, in @entity167 withdrawal respond to intensive supportive care. However, pharmacotherapy is essential for nonresponders and @entity1 with @entity1833 .
